Literature DB >> 20688898

Wnt/beta-catenin signaling in T-cell immunity and cancer immunotherapy.

Luca Gattinoni1, Yun Ji, Nicholas P Restifo.   

Abstract

Wnt ligands are lipid-modified secreted glycoproteins that regulate embryonic development, cell fate specification, and the homeostasis of self-renewing adult tissues. In addition to its well-established role in thymocyte development, recent studies have indicated that Wnt/β-catenin signaling is critical for the differentiation, polarization, and survival of mature T lymphocytes. Here, we describe our current understanding of Wnt signaling in the biology of post-thymic T cells, and discuss how harnessing the Wnt/β-catenin pathway might improve the efficacy of vaccines, T-cell-based therapies, and allogeneic stem cell transplantation for the treatment of patients with cancer. ©2010 AACR.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20688898      PMCID: PMC3393131          DOI: 10.1158/1078-0432.CCR-10-0356

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  66 in total

1.  Essential role of the Wnt pathway effector Tcf-1 for the establishment of functional CD8 T cell memory.

Authors:  Grégoire Jeannet; Caroline Boudousquié; Noémie Gardiol; Joonsoo Kang; Joerg Huelsken; Werner Held
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-10       Impact factor: 11.205

2.  Beta-catenin does not regulate memory T cell phenotype.

Authors:  Gregory Driessens; Yan Zheng; Thomas F Gajewski
Journal:  Nat Med       Date:  2010-05       Impact factor: 53.440

Review 3.  Targeting Wnt signaling: can we safely eradicate cancer stem cells?

Authors:  Fumi Takahashi-Yanaga; Michael Kahn
Journal:  Clin Cancer Res       Date:  2010-06-08       Impact factor: 12.531

4.  Distinct roles for IL-2 and IL-15 in the differentiation and survival of CD8+ effector and memory T cells.

Authors:  Diana M Mitchell; Eugene V Ravkov; Matthew A Williams
Journal:  J Immunol       Date:  2010-05-14       Impact factor: 5.422

5.  AMP-activated protein kinase (AMPK) cross-talks with canonical Wnt signaling via phosphorylation of beta-catenin at Ser 552.

Authors:  Junxing Zhao; Wanfu Yue; Mei J Zhu; Nair Sreejayan; Min Du
Journal:  Biochem Biophys Res Commun       Date:  2010-03-31       Impact factor: 3.575

6.  APCDD1 is a novel Wnt inhibitor mutated in hereditary hypotrichosis simplex.

Authors:  Yutaka Shimomura; Dritan Agalliu; Alin Vonica; Victor Luria; Muhammad Wajid; Alessandra Baumer; Serena Belli; Lynn Petukhova; Albert Schinzel; Ali H Brivanlou; Ben A Barres; Angela M Christiano
Journal:  Nature       Date:  2010-04-15       Impact factor: 49.962

7.  An HMG-box-containing T-cell factor required for thymocyte differentiation.

Authors:  S Verbeek; D Izon; F Hofhuis; E Robanus-Maandag; H te Riele; M van de Wetering; M Oosterwegel; A Wilson; H R MacDonald; H Clevers
Journal:  Nature       Date:  1995-03-02       Impact factor: 49.962

Review 8.  TCF1 and beta-catenin regulate T cell development and function.

Authors:  Qing Yu; Archna Sharma; Jyoti Misra Sen
Journal:  Immunol Res       Date:  2010-07       Impact factor: 2.829

9.  Cancer immunotherapy: moving beyond current vaccines.

Authors:  Steven A Rosenberg; James C Yang; Nicholas P Restifo
Journal:  Nat Med       Date:  2004-09       Impact factor: 53.440

10.  The human TCF-1 gene encodes a nuclear DNA-binding protein uniquely expressed in normal and neoplastic T-lineage lymphocytes.

Authors:  J Castrop; D van Wichen; M Koomans-Bitter; M van de Wetering; R de Weger; J van Dongen; H Clevers
Journal:  Blood       Date:  1995-10-15       Impact factor: 22.113

View more
  94 in total

1.  NKG2D receptor regulates human effector T-cell cytokine production.

Authors:  Amorette Barber; Charles L Sentman
Journal:  Blood       Date:  2011-04-25       Impact factor: 22.113

Review 2.  Adoptive T-cell therapy using autologous tumor-infiltrating lymphocytes for metastatic melanoma: current status and future outlook.

Authors:  Richard Wu; Marie-Andrée Forget; Jessica Chacon; Chantale Bernatchez; Cara Haymaker; Jie Qing Chen; Patrick Hwu; Laszlo G Radvanyi
Journal:  Cancer J       Date:  2012 Mar-Apr       Impact factor: 3.360

Review 3.  Therapeutic cancer vaccines: are we there yet?

Authors:  Christopher A Klebanoff; Nicolas Acquavella; Zhiya Yu; Nicholas P Restifo
Journal:  Immunol Rev       Date:  2011-01       Impact factor: 12.988

4.  A quantitative systems approach to identify paracrine mechanisms that locally suppress immune response to Interleukin-12 in the B16 melanoma model.

Authors:  Yogesh M Kulkarni; Emily Chambers; A J Robert McGray; Jason S Ware; Jonathan L Bramson; David J Klinke
Journal:  Integr Biol (Camb)       Date:  2012-07-09       Impact factor: 2.192

Review 5.  Genome organizing function of SATB1 in tumor progression.

Authors:  Terumi Kohwi-Shigematsu; Krzysztof Poterlowicz; Ellen Ordinario; Hye-Jung Han; Vladimir A Botchkarev; Yoshinori Kohwi
Journal:  Semin Cancer Biol       Date:  2012-07-04       Impact factor: 15.707

6.  Systematic mapping of WNT-FZD protein interactions reveals functional selectivity by distinct WNT-FZD pairs.

Authors:  Jacomijn P Dijksterhuis; Bolormaa Baljinnyam; Karen Stanger; Hakki O Sercan; Yun Ji; Osler Andres; Jeffrey S Rubin; Rami N Hannoush; Gunnar Schulte
Journal:  J Biol Chem       Date:  2015-01-20       Impact factor: 5.157

7.  β-catenin and PI3Kδ inhibition expands precursor Th17 cells with heightened stemness and antitumor activity.

Authors:  Kinga Majchrzak; Michelle H Nelson; Jacob S Bowers; Stefanie R Bailey; Megan M Wyatt; John M Wrangle; Mark P Rubinstein; Juan C Varela; Zihai Li; Richard A Himes; Sherine Sl Chan; Chrystal M Paulos
Journal:  JCI Insight       Date:  2017-04-20

Review 8.  Uncoupling T-cell expansion from effector differentiation in cell-based immunotherapy.

Authors:  Joseph G Crompton; Madhusudhanan Sukumar; Nicholas P Restifo
Journal:  Immunol Rev       Date:  2014-01       Impact factor: 12.988

Review 9.  Sorting through subsets: which T-cell populations mediate highly effective adoptive immunotherapy?

Authors:  Christopher A Klebanoff; Luca Gattinoni; Nicholas P Restifo
Journal:  J Immunother       Date:  2012 Nov-Dec       Impact factor: 4.456

10.  CEACAM1 regulates Fas-mediated apoptosis in Jurkat T-cells via its interaction with β-catenin.

Authors:  Yun Li; John E Shively
Journal:  Exp Cell Res       Date:  2013-03-07       Impact factor: 3.905

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.